BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sa-Nguanmoo N, Namdee K, Khongkow M, Ruktanonchai U, Zhao Y, Liang XJ. Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform. Nano Res 2021;:1-30. [PMID: 34659650 DOI: 10.1007/s12274-021-3832-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu S, Zhao Y, Guo L, Yu Q. Amoeba-inspired magnetic microgel assembly assisted by engineered dextran-binding protein for vaccination against life-threatening systemic infection. Nano Res 2023;16:938-50. [PMID: 36090612 DOI: 10.1007/s12274-022-4809-1] [Reference Citation Analysis]
2 Sarangi MK, Padhi S, Rath G, Nanda SS, Yi DK. Success of nano-vaccines against COVID-19: a transformation in nanomedicine. Expert Rev Vaccines 2022;21:1739-61. [PMID: 36384360 DOI: 10.1080/14760584.2022.2148659] [Reference Citation Analysis]
3 Tu B, Gao Y, An X, Wang H, Huang Y. Localized delivery of nanomedicine and antibodies for combating COVID-19. Acta Pharm Sin B 2022. [PMID: 36168329 DOI: 10.1016/j.apsb.2022.09.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Dri DA, Gaucci E, Torrieri I, Carafa M, Marianecci C, Gramaglia D. Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials Office. Pharmaceutics 2022;14:1438. [PMID: 35890333 DOI: 10.3390/pharmaceutics14071438] [Reference Citation Analysis]